🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase Ib/II, open-label, single institution dose-escalation, safe...
Status
Terminated
Location
University of Texas Health Science Center at San Antonio
Start Date
2024-12-27
Trial ID
NCT06516887
Treatments Being Tested
A multicenter, randomized, controlled, open-label, Phase II/III clinical tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-05
Trial ID
NCT07535567
Treatments Being Tested
A Phase 1/2 multi-center open-label study of BGB324 (bemcentinib) as a sing...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2015-04-19
Trial ID
NCT02424617
Treatments Being Tested
The aims of this Study were to determine: * How much of the Study Drug (be...
Status
Completed
Location
Labcorp Clinical Research Unit Ltd.
Start Date
2022-08-02
Trial ID
NCT06469138
Treatments Being Tested
Determine the overall response rate (ORR) of bemcentinib plus chemotherapy ...
Status
Terminated
Location
University of Texas Southwestern Medical Center
Start Date
2019-01-03
Trial ID
NCT03649321
Treatments Being Tested
A Multicenter, Randomized, Controlled, Open-Label, Phase III Clinical Trial...
Status
Recruiting
Location
Shanghai 9th people's hospital
Start Date
2026-03-04
Trial ID
NCT07445048
Treatments Being Tested
The primary purpose of this study is to determine the safety and tolerabili...
Status
Terminated
Location
Mount Sinai Comprehensive Cancer Center
Start Date
2023-03-03
Trial ID
NCT05469178
Treatments Being Tested
This study is being done to evaluate the safety of the investigational stud...
Status
Completed
Location
University of Texas Southwestern Medical Center
Start Date
2016-11
Trial ID
NCT02922777
This is an open-label, multi-center, single arm, phase II study to assess t...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center (DHMC)
Start Date
2017-10-02
Trial ID
NCT03184571
Treatments Being Tested
A Phase Ib/II multicentre open label study of bemcentinib (BGB324) as a sin...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2014-10-22
Trial ID
NCT02488408
Treatments Being Tested